Top 50 Medical Device VC Funds & Investors in Australia (September 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Artesian VC
VC Fund
|
21 | Australia, United States, Hong Kong | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Health Care | $65k–$15M |
|
Brandon Capital
VC Fund
|
8 | Australia, United Kingdom, United States | Series A, Seed, Series B | Biotechnology, Health Care, Medical | $673k–$81M |
|
Medical Research Commercialisation Fund (MRCF)
VC Fund
|
6 | Australia, United States, United Kingdom | Series A, Seed, Venture - Series Unknown | Biotechnology, Health Care, Medical | $1.3M–$35M |
|
Uniseed
VC Fund
|
5 | Australia, United States, United Kingdom | Series A, Seed, Series B | Biotechnology, Manufacturing, Health Care | $471k–$22M |
|
Flying Fox Ventures
VC Fund
|
5 | Australia, New Zealand, United States | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Information Technology | $120k–$11M |
|
Breakthrough Victoria
VC Fund
|
5 | Australia, United States, Philippines | Seed, Venture - Series Unknown, Series A | Health Care, Manufacturing, Biotechnology | $500k–$35M |
|
Brisbane Angels
VC Fund
|
4 | Australia, New Zealand, United States | Seed, Venture - Series Unknown, Pre-Seed | Software, Information Technology, Health Care | $120k–$2.1M |
|
Melbourne Angels
VC Fund
|
4 | Australia, United States, New Zealand | Seed, Angel | Software, Information Technology, Biotechnology | $34k–$1.5M |
|
Sydney Angels
VC Fund
|
4 | Australia, United States | Seed, Angel, Pre-Seed | Software, SaaS, E-Commerce | $120k–$1.5M |
|
Everywhere Ventures
VC Fund
|
4 | United States, Australia, India | Pre-Seed, Seed, Series A | Software, Health Care, FinTech | $250k–$20M |
|
b2venture
VC Fund
|
3 | Germany, Switzerland, United Kingdom | Series A, Seed, Series B | Software, Health Care, Information Technology | $1.4M–$52M |
|
Significant Ventures
VC Fund
|
3 | Australia, United States | Seed, Series A | Manufacturing, Software, Health Care | $77k–$8.2M |
|
Boson Ventures
VC Fund
|
2 | Australia | Seed, Pre-Seed, Series A | Financial Services, FinTech, Payments | $650k–$3M |
|
Future of Healthcare Fund - Australian Unity
VC Fund
|
2 | Australia | Series A | Health Care, Medical Device, Medical | $3.4M–$6.6M |
|
Left Lane Capital
VC Fund
|
2 | United States, Germany, Canada | Series A, Series B, Seed | FinTech, Financial Services, Software | $2.5M–$100M |
|
Renew Pharmaceuticals
VC Fund
|
2 | Australia | Series A, Series B | Health Care, Biotechnology, Medical Device | $5.6M–$6M |
|
Clare Ventures
VC Fund
|
2 | Australia | Series A | Health Care, Medical Device | $1.2M–$4.7M |
|
Horizons Ventures
VC Fund
|
2 | United States, United Kingdom, Canada | Series A, Series B, Seed | Biotechnology, Software, Artificial Intelligence | $1M–$110M |
|
Fund WA
VC Fund
|
2 | Australia | Seed, Series A | Medical, Health Care, Manufacturing | |
|
Development Bank of Wales
VC Fund
|
2 | United Kingdom, Australia, United States | Seed, Debt Financing, Venture - Series Unknown | Software, Health Care, Manufacturing | $19k–$5.4M |
|
SFC Capital
VC Fund
|
2 | United Kingdom, United States, Canada | Pre-Seed, Seed | Artificial Intelligence, Software, Information Technology | $127k–$2M |
|
South Australian Venture Capital Fund
VC Fund
|
2 | Australia | Seed, Series B, Series A | Health Care, Biotechnology, Internet of Things | $1M–$26M |
|
Anova Capital
VC Fund
|
2 | China, Australia | Seed, Series A | Education, Rental, Travel | $1.5M–$4.6M |
|
Uniseed Ventures
VC Fund
|
2 | Australia, United States, United Kingdom | Series A, Seed, Series B | Biotechnology, Health Care, Manufacturing | $381k–$94M |
|
Regal Funds Management
VC Fund
|
2 | Australia, United States, United Kingdom | Convertible Note, Series B, Venture - Series Unknown | Software, FinTech, Financial Services | $1.9M–$100M |
|
CoAct Capital
VC Fund
|
2 | Australia, New Zealand | Series A, Seed, Series B | Software, Information Technology, SaaS | $4.4M–$14M |
|
UniSA Ventures
VC Fund
|
2 | Australia | Seed, Pre-Seed | Software, Health Care, Biotechnology | |
|
CP Ventures
VC Fund
|
2 | Australia, United States, India | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, Machine Learning | $150k–$12M |
|
Victoria University of Wellington
VC Fund
|
2 | Australia | Seed, Pre-Seed | Health Care, Biotechnology, Medical Device | |
|
Global Health Investment Fund (GHIF)
VC Fund
|
2 | United States, India, Austria | Series B, Series C, Venture - Series Unknown | Health Care, Biotechnology, Medical Device | $3.5M–$25M |
|
Sirius Capital
VC Fund
|
2 | China, Australia | Series A, Venture - Series Unknown, Seed | Artificial Intelligence, Robotics, Health Care | $1.4M–$50M |
|
Sprint Ventures
VC Fund
|
2 | Australia, United States | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Health Care | $655k–$10M |
|
Monash Ventures
VC Fund
|
1 | Australia, Philippines, United States | Pre-Seed | Medical, Health Care, Biotechnology | |
|
Rohto Pharmaceutical
VC Fund
|
1 | Japan, Israel, Australia | Series B, Seed, Series C | Health Care, Manufacturing, Medical | $11M–$283M |
|
AfterWork Ventures
VC Fund
|
1 | Australia, United States, New Zealand | Seed, Pre-Seed, Series A | Software, FinTech, Financial Services | $410k–$22M |
|
Terra Rossa Capital
VC Fund
|
1 | Australia | Series A, Series B | Health Care, Biotechnology, Medical Device | |
|
Microsoft for Startups
VC Fund
|
1 | United States, India, Canada | Seed, Pre-Seed | Software, Information Technology, SaaS | |
|
SOSV
VC Fund
|
1 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | |
|
Avicella Capital
VC Fund
|
1 | Australia | Series A, Series B | Therapeutics, Medical, Robotics | $3.1M–$25M |
|
SPRIM Global Investments
VC Fund
|
1 | France, Australia, United States | Series A, Debt Financing | Biotechnology, Health Care, Medical Device | $500k–$26M |
|
PsyMed Ventures
VC Fund
|
1 | United States, Canada, Israel | Seed, Series A, Pre-Seed | Health Care, Biotechnology, Medical | $680k–$70M |
|
Powerhouse Ventures
VC Fund
|
1 | United States, Canada, United Kingdom | Seed, Series A, Pre-Seed | Software, Energy, Solar | $1.1M–$30M |
|
Playford Capital
VC Fund
|
1 | Australia | Series A, Series B | Health Care, Biotechnology, Medical Device | |
|
Skip Capital
VC Fund
|
1 | Australia, United States, Canada | Seed, Series A, Series B | Software, Artificial Intelligence, SaaS | $1.4M–$94M |
|
Starfish Ventures
VC Fund
|
1 | Australia, United States, Philippines | Series A, Series B | Software, Enterprise Software, Internet | $2M–$18M |
|
Transition Level Investments
VC Fund
|
1 | Australia, United States, Colombia | Seed, Venture - Series Unknown, Series A | Software, Apps, SaaS | $383k–$16M |
|
Yamaha Motor Ventures
VC Fund
|
1 | United States, Canada, Australia | Series A, Seed, Series B | Artificial Intelligence, Robotics, Health Care | $2M–$43M |
|
Giant Leap Fund
VC Fund
|
1 | Australia, United States, Philippines | Seed, Series A, Venture - Series Unknown | Health Care, Software, Information Technology | $941k–$25M |
|
Ramsay Health Care
VC Fund
|
1 | Australia | Series A | Medical, Health Care, Medical Device | |
|
Versant Ventures
VC Fund
|
1 | United States, Switzerland, Canada | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $5M–$108M |
| Access all 191 VC funds in Australia Medical Device startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Australia, United States, Hong Kong
Investor stats
- Total investments: 619
- Round size: Seed $65k–$4.6M; Pre-Seed $70k–$553k; Series A $2.3M–$15M
- Lead/follow: 37% lead, 63% follow
- Last fund: Likely still investing — raised $36M in 2023
Portfolio highlights
- CUZIN — CUZIN is your global shopping family. A community marketplace enabling members to purchase any product worldwide by leveraging other members’ buying access or advantages.Members post requests for any product they want from anywhere in the world. Online or offline, specialist boutiques/clearance outlets and sales. This request is pushed to'cuzins' best placed (geographically or commercially) to purchase the item on their behalf. Cuzins earn a tip for helping out!In addition to accepting a shopping request, any cuzin can instantly monetise being in the right place at the right time posting a purchase opportunity, which is pushed to interested members worldwide. Shopping, shipping, social. Sorted. CUZIN provides the social and logistics platform to facilitate the matching, communication, payment and shipping of the items we love worldwide.
- Vaulta — Vaulta is a battery casing technology company based in Brisbane, Australia. Using advanced composite materials and smart, streamlined design, Vaulta has developed a lighter and smaller battery case with fewer parts, creating scalable efficiencies and opportunities for manufacturers. Vaulta founder and director Dominic Spooner has over 12 yearsexperience as a design engineer, and has worked in a range of industries, including renewables and batteries, defence and aerospace, consumer products, commercial products and startups. While working in battery design, Dominic saw firsthand that opportunities for growth were being overlooked in favour of continuing with the status quo – and that’s when the idea for Vaulta was born.Vaulta’s world-first no-weld design means modules can be easily assembled and disassembled, cells reused and recycled, and new cells added as battery technology continues to evolve.From stationary storage and electric vehicles to defence, aerospace and beyond, Vaulta’s battery case technology works wherever batteries do.
- Andromeda Robotics — At Andromeda, our personalised robot companions are helping Australian aged care teams bring joy and connection to residents to improve wellbeing.
Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Seed, Series B
- Geography: Australia, United Kingdom, United States
Investor stats
- Total investments: 83
- Round size: Seed $673k–$9.7M; Series A $5.2M–$81M; Series B $6.4M–$68M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely actively investing — fresh fund, raised $290M in 2025
Portfolio highlights
- Ena Respiratory — Ena Respiratory is a biotechnology company seeking to transform the treatment and prevention of respiratory infections and the effectiveness of vaccines.Ena Respiratory novel, synthetic Toll-like receptor 2 (TLR2) receptor agonists have been shown to activate the innate immune system in the respiratory tract and prevent viral and bacterialdissemination to the lungs.
- Lumonus — Hello, we are Lumonus! We empower oncology care teams through software solutions and services.
- OncoRes Medical — OncoRes Medical develops an imaging technology to provide intraoperative information available to surgeons to assist with the identification of tumor and healthy tissue.OncoRes Medical is an early-stage medical device company located in Perth, Western Australia and is developing the patent-protected technology in collaboration with leadingresearchers at the University of Western Australia and the Harry Perkins Institute of Medical Research and breast cancer surgeons at the Western Australian public health system.With funding provided by the Medical Research Commercialisation Fund (MRCF), OncoRes Medical aims to develop the technology for use in clinical applications that require the real-time assessment of tissue microstructure.
Medical Research Commercialisation Fund (MRCF) provides dedicated, investment funding to support the commercialisation of early-stage medical research discoveries that originate from its member institutes. The collaborative nature of the MRCF seeks to foster best practice in the commercialisation of medical innovations.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Seed, Venture - Series Unknown
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 32
- Round size: Seed $1.3M–$1.7M; Series A $1.3M–$13M; Venture - Series Unknown $4.3M–$35M
- Lead/follow: 44% lead, 56% follow
Portfolio highlights
- MycRx — MecRx is a drug development company that works on new treatments for cancer and novel mechanism of action antibiotics. Using proprietary “hit identification” technology, MecRx is developing inhibitors of cMyc, a protein that is deregulated in over 50% of all human cancers. MecRx draws on the expertise of the Peter MacCallum Cancer Centre and CSIROand is headquartered in Melbourne, Australia.MecRx was founded in 2013 by an ex-pharma/biotech team. MecRx is run as a virtual company based in Melbourne, Australia and its shareholders and service providers include the Peter MacCallum Cancer Institute and CSIRO. The company secured $5m Series A investment from the MRCF (www.mrcf.com.au) and CSIRO in 2015.
- Currus Biologics — Currus Biologics develops BEAT technology to advance CAR T-cell therapy for solid tumors, aiming to improve treatment outcomes in oncology.
- Azura Ophthalmics — Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD, the leading cause of DED. By targeting the root cause of MGD, Azura brings the promise of improved health and well-being to millions of people worldwide who suffer from MGD and other ocular surface diseases where treatmentoptions are currently lacking. Azura is underpinned by an experienced management team with an established track record of successfully developing and commercializing novel treatments for ocular surface diseases. The company headquartered in Tel Aviv-Yafo, Israel with operations in Australia and the U.S.
Uniseed is Australia's first, and longest running, university owned venture fund. Established in 2000, we are owned by 9 universities plus CSIRO (behind over 60% of Australia's research) and fund deep-tech spinouts through to global scale.
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Health Care
- Stage:Series A, Seed, Series B
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 89
- Round size: Seed $670k–$3.5M; Series A $1.6M–$16M; Series B $471k–$22M
- Lead/follow: 21% lead, 79% follow
- Last fund: May invest from a new fund soon — raised $15M in 2017
Portfolio highlights
- DeteQt — Semiconductor chip-based quantum magnetic field sensors using diamond - navigation, mining, medical imaging
- Plasmaleap — Plasmaleap is a plasma technology company that manufactures and sells zero-emissions chemical reactors designed for industrial and energy applications. The company develops reactor systems that use plasma processes to enable chemical production and transformation without relying on conventional combustion methods. Its technology supports sectorssuch as clean fuels, chemical manufacturing, and materials processing by offering electrified reactor solutions that can be integrated into existing industrial workflows. Plasmaleap designs modular systems that allow operators to deploy plasma reactors for on-site production and conversion of feedstocks using electricity as the primary energy input. The company also provides engineering support and technical integration services to help customers incorporate its reactor technology into commercial operations. Through its plasma-based approach, Plasmaleap focuses on enabling chemical processes that align with decarbonization and emissions reduction objectives across multiple industries.
- Facet Amtech — Facet Amtech develops and produces ammonia from water and air.
Flying Fox Ventures is an early stage investment firm that invests across industry and across the micro-stages of pre-seed and seed.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: Australia, New Zealand, United States
Investor stats
- Total investments: 112
- Round size: Seed $662k–$3.2M; Pre-Seed $120k–$3M; Series A $649k–$11M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- Operata — Continuously measure performance to deliver the best possible customer experience.
- SPEC Toolbox — Structural timber design software for Australian engineers. Design CLT, GLT, and connections to AS1720 standards. Start your free trial and automate today.
- Teacher’s Buddy — Create lesson plans, worksheets, assessments, and more in minutes. AI-powered tools designed for educators.
The Breakthrough Victoria Fund is a $2 billion investment by the Victorian Government to drive investment in research and innovation.
Show more...Investment focus
- Industry: Health Care, Manufacturing, Biotechnology
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Australia, United States, Philippines
Investor stats
- Total investments: 55
- Round size: Seed $708k–$6.8M; Series A $4M–$35M; Venture - Series Unknown $500k–$30M
- Lead/follow: 53% lead, 47% follow
Portfolio highlights
- AlleSense — AlleSense has developed a unique and novel solution to label-free imaging, the NanoMslide.
- Mental Jam — We are a games studio dedicated to creating impactful experiences that explore mental health.
- Deftbiotech — Deftbiotech is a biotech startup developing peptide-based antifungal treatments for nail and skin infections.
Formed in late 2006, the Brisbane Angels Pty Ltd is a large group of private investors who actively invest in early stage technology companies, usually in South East Queensland, Australia. The members are typically active or semi-retired former senior business executives, who apart from financial input can provide much needed value adding toinvestee companies through hands-on management experience and high level business networks.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Venture - Series Unknown, Pre-Seed
- Geography: Australia, New Zealand, United States
Investor stats
- Total investments: 104
- Round size: Seed $120k–$2.1M; Pre-Seed $200k–$1.4M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- Giftbee — Giftbee reshapes gifting for businesses and consumers. Send gifts with flexibility to accept, swap, or give forward. Manage gifting programs, reduce waste, and create meaningful impact.
- Indi — Connect the village around your child and track what matters. Organise records, therapy goals and your care team in one place.
- Ovum — Meet Ovum, the intelligent health journal mobile app designed for womankind.
Melbourne Angels is the most active startup investor in Victoria, one of the most active in Australia. Investing in start-ups since 2007, Melbourne Angels is committed to helping innovative founders build the next generation of our economy.
Show more...Investment focus
- Industry: Software, Information Technology, Biotechnology
- Stage:Seed, Angel
- Geography: Australia, United States, New Zealand
Investor stats
- Total investments: 67
- Round size: Seed $34k–$1.5M; Angel $200k–$918k
- Lead/follow: 37% lead, 63% follow
Portfolio highlights
- Emanda — Thinking about selling your business in Australia? Emanda guides you through every step: business valuation, health check, corporate compliance, and sale process. Start with a business valuation.
- Auric Essentials — Auric - The Power of Scent. Revolutionise your well-being with Auric. Discover our state-of-the-art AI-powered AromaSphere diffuser and app, designed to personalise your aromatherapy experience.
- Bitwise Agronomy — Bitwise Agronomy uses AI to analyze crop video footage and provide growers with insights into crop health, growth, and yield potential.
Sydney Angels is a not-for-profit angel investment membership organisation. Since our establishment in 2008, they have stayed true to our mission of supporting the early-stage ecosystem by running processes and events that connect our investing members with promising early-stage companiesThey believe that encouraging smart investment in startupcompanies will benefit both our members’ portfolios and Australia’s emergent innovation economy.They see this as the ultimate win-win situation. Sydney Angels is led by an elected committee of ten volunteers who meet weekly. It is supported by an operations manager and alliance partners.
Show more...Investment focus
- Industry: Software, SaaS, E-Commerce
- Stage:Seed, Angel, Pre-Seed
- Geography: Australia, United States
Investor stats
- Total investments: 99
- Round size: Seed $120k–$1.5M; Angel $130k–$1.1M; Pre-Seed $337k–$1.5M
- Lead/follow: 35% lead, 65% follow
- Last fund: May invest from a new fund soon — last raise in 2016
Portfolio highlights
- Keeyu — keeyu. is a B2B SaaS platform that continuously monitors e-commerce transactions from payment to delivery. Should any issue emerge, our system immediately notifies the customer service team, enabling proactive issue resolution before it impacts the customer, saving them from opening a support ticket. The result is an enhanced post-purchaseexperience, ensuring sales retention and reducing customer complaints.Founded in 2023, the company is headquartered in Sydney, Australia, and is dedicated to empowering businesses to deliver exceptional post-purchase experiences.
- iiShield — iiShield aims to improve patient outcomes and surgeon training in transplant surgery by providing effective organ heat protection.
- Mary Technology — Generate detailed chronologies from documents in minutes with Mary Technology. Achieve 90%+ time reduction and ensure 99%+ accuracy. Try for free.
Everywhere Ventures is a global pre-seed venture capital fund for founders, by founders. Click to read Everywhere VC, by Everywhere Ventures, a Substack publication with tens of thousands of subscribers.
Show more...Investment focus
- Industry: Software, Health Care, FinTech
- Stage:Pre-Seed, Seed, Series A
- Geography: United States, Australia, India
Investor stats
- Total investments: 1303
- Round size: Seed $1M–$6.5M; Pre-Seed $250k–$2.5M; Series A $6M–$20M
- Lead/follow: 2% lead, 98% follow
- Last fund: Likely actively investing — fresh fund, raised $4.4M in 2026
Portfolio highlights
- Donna — Meet Donna, the AI assistant built for field sales teams. Save time, cut admin, and close more deals with less effort.
- Keebler Health — AI-Enabled Coding for Medical Billing Teams
- Neurometric AI — Making Intelligence Free | https://t.co/ZxWxeMBJt2 | https://t.co/W8nlLqYwQi
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!B2venture is a venture capital firm focused on early-stage investments in digital and industrial technology companies. B2venture invests EUR 100m+ per year in high-growth companies with ticket sizes from EUR 0.25m to 3.5m.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Series A, Seed, Series B
- Geography: Germany, Switzerland, United Kingdom
Investor stats
- Total investments: 266
- Round size: Seed $1.4M–$8.8M; Series A $4M–$23M; Series B $8M–$52M
- Lead/follow: 28% lead, 72% follow
- Last fund: Likely actively investing — fresh fund, raised $179M in 2026
Portfolio highlights
- Everlab — The preventative health service of the future. Detect disease early, improve wellbeing, and optimise performance.
- Flyboard — Human-level AI voice agents at a fraction of the cost. Transform your customer engagement with intelligent automation.
- Kiin Bio — Accelerate drug discovery with Virtual Scientists. Unified platform integrating 100+ specialized tools into one intelligent workflow.
Significant Ventures is an early-stage venture capital fund backing transformative technologies and the ambitious founders behind them.Founded by the Hindmarsh family, Significant Ventures invests in deep tech, applied science and research-driven innovation emerging from Australia’s leading universities and research institutions. The fundcombines capital with active, hands-on support—helping early-stage companies shape their strategy, attract talent, and access follow-on funding.With a network of expert operators, advisors and institutional partners, Significant Ventures focuses on turning high-potential ideas into globally scalable businesses. The team works closely with founders across sectors including life sciences, climate tech, AI, education and advanced manufacturing.Driven by a commitment to impact, collaboration and long-term value creation, Significant Ventures exists to build the next generation of high-growth companies that will lead Australia’s innovation economy
Show more...Investment focus
- Industry: Manufacturing, Software, Health Care
- Stage:Seed, Series A
- Geography: Australia, United States
Investor stats
- Total investments: 26
- Round size: Seed $77k–$4.8M; Series A $4.5M–$8.2M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Earthodic — Earthodic is an Australian materials science company creating functional biobased coatings. Paperbarc by Earthodic is a biobased water-resistant coating for pulped or paper products. It has better water-resistance than wax coatings, more sustainable and circular than plastic coatings. Repulpable. Re
- Hearables 3D — Scale your custom-fit volumes and solve dental lab technician shortage with AI and automation solutions.
- Visionary Machines — Superior perception for next-generation autonomy
Investor for disruptors and force carrier for impact! We are an Australian Venture Capital that backs visionary founders of all backgrounds and grows exceptional deep tech or business model innovation companies to become truly transformative!
Show more...Investment focus
- Industry: Financial Services, FinTech, Payments
- Stage:Seed, Pre-Seed, Series A
- Geography: Australia
Investor stats
- Total investments: 11
- Round size: Seed $650k–$3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- AI-NC — Platform to connect engineers and manufacturers, and provide them with the right tools to streamline the process.
- Catalyser — Catalyser is customizable cloud software for better employee giving. It specializes in managing and growing employee giving in the workplace by volunteering, fundraising, payroll giving, appeals, and pro bono. the company involves in increasing employee engagement and social responsibility.
- Kite Magnetics — Electric motors enabling electric aircraft of all sizes to fly further, carry more and emit less. The future of aviation is electric.
A fund focused on delivering long term capital growth whilst increasing the wellbeing of Australians by investing in the future healthcare needs of Australians.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series A
- Geography: Australia
Investor stats
- Total investments: 2
- Round size: Series A $3.4M–$6.6M
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Oli — Baymatob is an AI-guided solution to improve health outcomes for mothers and their babies.
- OncoRes Medical — OncoRes Medical develops an imaging technology to provide intraoperative information available to surgeons to assist with the identification of tumor and healthy tissue.OncoRes Medical is an early-stage medical device company located in Perth, Western Australia and is developing the patent-protected technology in collaboration with leadingresearchers at the University of Western Australia and the Harry Perkins Institute of Medical Research and breast cancer surgeons at the Western Australian public health system.With funding provided by the Medical Research Commercialisation Fund (MRCF), OncoRes Medical aims to develop the technology for use in clinical applications that require the real-time assessment of tissue microstructure.
Left Lane Capital is a venture capital and seed-growth equity firm that invests in high-growth internet and consumer technology businesses that are fundamental to the human condition and spirit – where customers maintain a long-term relationship with the product, platform, or service.
Show more...Investment focus
- Industry: FinTech, Financial Services, Software
- Stage:Series A, Series B, Seed
- Geography: United States, Germany, Canada
Investor stats
- Total investments: 177
- Round size: Seed $2.5M–$20M; Series A $9.4M–$40M; Series B $23M–$100M
- Lead/follow: 59% lead, 41% follow
- Last fund: Likely still investing — raised $1.4B in 2022
Portfolio highlights
- Lexroom.ai — Lexroom.ai allows lawyers to complete hours of legal research in seconds.Legal professionals spend up to 50% of their time in repetitive, low value-adding tasks. That’s why we’re building Lexroom.ai, a product that allows lawyers to complete hours of research in seconds, so they can focus on what really matters.Lexroom.ai perfectly integrateswith lawyers' daily workflow and enables them to speed up time-consuming legal research tasks while increasing output quality, so that they can focus more on value-adding activities.Lexroom.ai is building a bridge between advanced artificial intelligence technologies and legal professionals, through a product specifically tailored to their needs.
- Moove — Moove is a mobility fintech that provides revenue-based vehicle financing to mobility entrepreneurs, democratizing vehicle ownership across Africa. The company embeds its alternative credit-scoring technology onto ride-hailing, logistics, and last-mile/instant delivery platforms, which allows access to proprietary performance and revenueanalytics of mobility entrepreneurs to underwrite loans.
- Blank Street — Blank Street is a small-format coffee shop with big dreams. Our mission is to reinvent local commerce to better serve our customers, neighborhoods, and planet.
Renew Pharmaceuticals is an healthcare company.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Series B
- Geography: Australia
Investor stats
- Total investments: 3
- Round size: Series A $5.6M–$6M
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
Clare Ventures provides the capital female-founded businesses deserve to innovate, scale and create lasting impact.
Show more...Investment focus
- Industry: Health Care, Medical Device
- Stage:Series A
- Geography: Australia
Investor stats
- Total investments: 2
- Round size: Series A $1.2M–$4.7M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Oli — Baymatob is an AI-guided solution to improve health outcomes for mothers and their babies.
Investing in the deep science and technology that can propel humanity towards a radically better future.
Show more...Investment focus
- Industry: Biotechnology, Software, Artificial Intelligence
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 321
- Round size: Seed $1M–$10M; Series A $6.2M–$47M; Series B $11M–$110M
- Lead/follow: 42% lead, 58% follow
Portfolio highlights
- HZO — HZO delivers customized protective nano and conformal coatings that safeguard electronics from the most demanding environments. It provides water protection solutions for electronics manufacturers by introducing a durable film to components during assembly. The company specializes in the fields of nanotechnology, waterproofing, electronics,nano-coating, full-submersion.It was founded in 2011 and headquartered in Morrisville, North Carolina.
- Cortica — Cortica is an Israeli company founded in 2007 with leading AI technology for visual perception. Its unique self-learning technology, backed by more than 200 patents, allows Cortica to develop multiple products that can read and understand images on a human level–thereby significantly exceeding the capabilities of the major tech companies.Cortica is the first AI company capable of human-level image understanding. Even the most advanced technology has never been able to understand the visual world as well as people do - until now. By leveraging proprietary brain research to create unsupervised AI, Cortica has developed the most effective computer vision system. This technology, based upon the mammal cortex is utilized to build products impacting many industries. The company’s mission is to lead the emerging AI market with a strong focus on computer vision and establish its "universal visual index of the world" as the global standard–enabling machines to read and understand images. Cortica's vision is to embed its capabilities in all next-generation platforms where understanding images is a critical task. This includes autonomous vehicles, smart city applications, security cameras, drones, media, robotics, and medical image analysis. Cortica's headquarters and R&D center are based in Israel employing over 80 leading AI researchers and veterans of elite Israeli military intelligence units.
- Corephotonics — Corephotonics is the pioneer and worldwide market leader of dual camera technologies for smartphones and mobile devices, providing a perfect mobile camera photography experience, novel photography features and superior image quality
FundWA is a Western Australian venture capital fund that invests in technology-enabled innovative businesses in Western Australia.
Show more...Investment focus
- Industry: Medical, Health Care, Manufacturing
- Stage:Seed, Series A
- Geography: Australia
Investor stats
- Total investments: 12
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Enzide — Enzide is an Australian company solving plastic pollution with new super enzyme technology based on years of research
- personr — Single source of truth for AML compliance
- Hola Health — 24 hour online doctors & GP consults via telehealth appointments in 15 minutes. Get instant scripts online, medical certificate online anywhere in Australia.
Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds.
Show more...Investment focus
- Industry: Software, Health Care, Manufacturing
- Stage:Seed, Debt Financing, Venture - Series Unknown
- Geography: United Kingdom, Australia, United States
Investor stats
- Total investments: 284
- Round size: Seed $365k–$3M; Debt Financing $19k–$3.7M; Venture - Series Unknown $383k–$5.4M
- Lead/follow: 63% lead, 37% follow
- Last fund: May invest from a new fund soon — raised $27M in 2018
Portfolio highlights
- Reacta Biotech — Reacta Biotech has been established to develop, manufacture and commercialise oral food challenge materials to pharmaceutical standards of Good Manufacturing Practice (GMP).
- Design and Supply — Design and Supply are specialist manufacturers and suppliers of Industrial Steel Doors and Architectural Products.
- MeOmics Technology — MeOmics Technology is a biotech company with a focus on improving the diagnosis and treatment of mental health illnesses. The company operates in the manufacturing industry and has a team of 9 employees. The team includes experts in Neuronal Cell Biology and Neuropsychopharmacology. The company's mission is to leverage technology to enhancethe understanding and treatment of mental health conditions.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Discover the UK's leading SEIS Fund, offering tax-efficient investments in innovative startups. Join thousands of savvy investors and raise capital for your business with SFC Capital.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Information Technology
- Stage:Pre-Seed, Seed
- Geography: United Kingdom, United States, Canada
Investor stats
- Total investments: 725
- Round size: Seed $127k–$2M; Pre-Seed $170k–$846k
- Lead/follow: 38% lead, 62% follow
- Last fund: May invest from a new fund soon — raised $1.9M in 2019
Portfolio highlights
- Keylr — Services partner for property managers. Book reliable, top-rated professionals for your properties with e-props.
- Furbnow — Furbnow - Your companion for home improvements for the future
- FlairMakers — FlairMakers provides a digital talent platform connecting hospitality businesses with vetted freelance professionals.
South Australian Venture Capital Fund - helping build dynamic and innovative South Australian startups / scaleups and accelerate their growth to a national and global scale.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Internet of Things
- Stage:Seed, Series B, Series A
- Geography: Australia
Investor stats
- Total investments: 14
- Round size: Seed $1M–$12M; Series A $2.3M–$20M; Series B $13M–$26M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
- Seonix Bio — Seonix Bio is dedicated to helping health professionals, individuals and researchers understand glaucoma risk using genetics.
- Pearler.AI — Pearler gives your team super powers to respond fast to RFP, RFI, RFQ, Security, Cyber, Risk & Grant Questionnaires.
Anova Capital focus on investment in education, big health and new consumption.
Show more...Investment focus
- Industry: Education, Rental, Travel
- Stage:Seed, Series A
- Geography: China, Australia
Investor stats
- Total investments: 4
- Round size: Seed $1.5M–$4.6M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Qukoucai — Qukoucai is an online interactive learning platform for children and children. It focuses on providing customized online personal eloquence courses for 4-12 years old children. It includes a complete closed-loop product of teaching, practice, evaluation and display, and is committed to improving children's eloquence. ability.
- Vantari VR — Virtual Reality for Healthcare
- Woody Library — Woody Library is the first subscription-based book sharing and rental platform in China. In the cabin, you can spend the least amount of money, read the most books, and never again, the book that bought the hand has turned over a few pages and found that it has no long-term collection value.
Uniseed is Australia's first, and longest running, university owned venture fund. Established in 2000, we are owned by 9 universities plus CSIRO (behind over 60% of Australia's research) and fund deep-tech spinouts through to global scale.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Series A, Seed, Series B
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 57
- Round size: Seed $381k–$4.6M; Series A $1.3M–$16M; Series B $404k–$94M
- Lead/follow: 12% lead, 88% follow
- Last fund: May invest from a new fund soon — raised $14M in 2017
Portfolio highlights
- BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture.
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
- Morse Micro — Morse Micro's Wi-Fi HaLow combines long-range, strong signal penetration, low power, and high throughput in one wireless protocol, delivering connectivity to more devices, at distance, with greater reliability.
Regal Funds Management was founded in 2004 by Andrew and Philip King. Regal utilises a long/short investment strategy and performs investment management and investment advisory services to a number of Australian Unit Trusts and Cayman Island Companies.
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Convertible Note, Series B, Venture - Series Unknown
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 85
- Round size: Series B $7M–$30M; Convertible Note $1.9M–$18M; Venture - Series Unknown $4.8M–$100M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely still investing — raised $52M in 2022
Portfolio highlights
- Send Payments — SendFX provides cross-border payment and remittance services to individuals and SMEs.
- Firmus Technologies — Building the cloud infrastructure of tomorrow, today.
- Iondrive — Iondrive is an exploration company that provides metals. They offer products that include gold, silver, copper, and other metals. They provide services for industrial use.
Co:Act is an investment partnership of experienced venture investors with a network of founders.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Series A, Seed, Series B
- Geography: Australia, New Zealand
Investor stats
- Total investments: 12
- Round size: Series A $4.4M–$14M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Veyor — The leading live scheduling app for the built environment, helping dispersed teams and their suppliers plan, manage and track daily activity on an easy to use mobile and desktop platform.
- OneReg — Designed specifically for Aviation - One powerful, integrated platform delivering full operational clarity, real-time compliance and smarter insights.
- EatClub — EatClub shows you nearby restaurants, with spare tables, offering last minute deals. Receive up to 50% off your bill (including drinks!)
UniSA Ventures is the technology commercialisation and investment management company of the University of South Australia (UniSA).
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Pre-Seed
- Geography: Australia
Investor stats
- Total investments: 3
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — raised $31M in 2019
Portfolio highlights
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
- Framework — Framework is an all-in-one tool for teams and individuals. You can use Framework to do anything from project management, sales pipeline & customer relationship management, wiki & documentation, team communication (team chat, voice & video calls), and meeting scheduling.Framework can help organize your ideas with nodes. A node is apiece of information and each node is connected and related to other nodes.
CP Ventures is a boutique, high-performance global venture capital firm backing breakthrough 4th Industrial Revolution technologies.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Machine Learning
- Stage:Seed, Pre-Seed, Series A
- Geography: Australia, United States, India
Investor stats
- Total investments: 90
- Round size: Seed $482k–$4.2M; Pre-Seed $150k–$900k; Series A $3.8M–$12M
- Lead/follow: 42% lead, 58% follow
Portfolio highlights
- LeadStory — Watch breaking news from around the world and stay up to date with current events. Follow topics that matter to you from providers you can trust. See whats happening nearby or in places you care about.
- Greenfly — Greenfly's short-form media orchestration software platform captures, collects, organizes & distributes videos & photos to drive fan engagement and boost revenue for sports and entertainment organizations.
- Skylark Labs — Skylark Labs develops continuously evolving and customizable threat detection systems for enhanced physical security. Our clients (CCTV or Drone companies) can customize our proprietary AI solutions at the time of deployment or continuously evolve them if needed after deployment making them preferable to other comparable market solutions.
A tradition of fostering strong global links in teaching and research and programmes of national significance and international quality.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Seed, Pre-Seed
- Geography: Australia
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
The Global Health Investment Fund (GHIF) is a $108 million social impact investment fund designed to provide financing to advance the development of drugs, vaccines, diagnostics and other interventions against diseases that disproportionately burden low- and middle-income countries. GHIF supports late-stage innovations for public health challengessuch as malaria, pre-eclampsia, cholera, HIV and river blindness, with an emphasis on infectious diseases and maternal/infant health issues that cause significant morbidity and mortality in resource-limited settings. GHIF may also make investments that improve or expand access to existing products—such as developing pediatric formulations of approved therapeutics or improving the stability of widely-used global health vaccines.As an investment fund with a limited time-horizon, GHIF seeks opportunities that have a high probability of successful commercialization within two or three years. Products with “dual market” potential are of greatest interest; i.e., those that will have a clear impact on public health in developing countries but also have value in high-income countries. High-volume / low-margin products, such as essential vaccines, are also of significant interest.GHIF employs a range of investment structures including mezzanine debt, convertible debt, preferred equity and project financing with an average investment target of approximately $10 million per project. Each GHIF project must advance the Fund’s social impact objectives and demonstrate the ability to achieve commercial success.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series B, Series C, Venture - Series Unknown
- Geography: United States, India, Austria
Investor stats
- Total investments: 21
- Round size: Series B $7.5M–$19M; Series C $4.5M–$14M; Venture - Series Unknown $3.5M–$25M
- Lead/follow: 43% lead, 57% follow
- Last fund: May invest from a new fund soon — raised $108M in 2012
Portfolio highlights
- Monod Bio — Monod Bio l Simple. Powerful. Biosensors for Medicine & Biotech.
- CXL Ophthalmics — CXLO is developing a minimally invasive treatment for an ectatic corneal disease that can bring early intervention to millions of patients globally.
- Endpoint Health — Endpoint Health is a precision-first therapeutics company. By rewriting the molecule-first drug development model, we aim to deliver precision therapies that have the potential to improve outcomes for patients with immune-driven illnesses.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Sirius Capital is a venture capital firm in China that invests in technology companies.
Show more...Investment focus
- Industry: Artificial Intelligence, Robotics, Health Care
- Stage:Series A, Venture - Series Unknown, Seed
- Geography: China, Australia
Investor stats
- Total investments: 16
- Round size: Seed $1.4M–$4.6M; Series A $7M–$50M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- Vantari VR — Virtual Reality for Healthcare
- Zenbot — Zenbot is a high-growth startup specializing in embodied intelligence infrastructure.
- Kuanfen Technology Realcome — Kuanfen Technology Realcome is a brand of AI virtual bloggers that focuses on the use of various AI technologies.
Early stage Venture Capital firm based in Brisbane that's investing in next generational Australian companies that are building a better future.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Australia, United States
Investor stats
- Total investments: 25
- Round size: Seed $655k–$2.4M; Series A $1.9M–$10M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- VAPAR — VAPAR offers CCTV pipe inspection software. The software is AI integrated for better results and accuracy. Prevent pipe failures and make informed pipe network decisions.
- Umps Health — Umps offers a 24/7 personal alarm that helps you live independently with peace of mind. Easy to use, always connected.
- Bitwise Agronomy — Bitwise Agronomy uses AI to analyze crop video footage and provide growers with insights into crop health, growth, and yield potential.
Monash Ventures is a newly launched initiative from Monash University that serves as the university's dedicated venture and investment arm. Its purpose is to finance and nurture spinout companies, commercialise research outcomes—particularly in the healthcare sector—and support early-stage research commercialisation.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Pre-Seed
- Geography: Australia, Philippines, United States
Investor stats
- Total investments: 3
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Fyton Bio — FytonBio is a privately held, preclinical-stage biopharmaceutical company specializing in biotechnology research. Their core mission is to achieve functional cures for autoimmune and inflammatory diseases by deleting pathogenic immune cells. The company focuses on developing monoclonal antibodies capable of highly specific depletion of such cellsto durably alter disease progression.
- Myostellar — Myostellar is creating a first-in-class, highly differentiated biologic therapy that stimulates muscle stem cells to promote muscle regeneration with no fibrosis.
- Remagine Labs — Remagine Labs is revolutionizing healthcare with a bluetooth-connected, wearable electro-pharmaceutical that provide patient-centered care and consistent drug administration, giving healthcare customers peace of mind all over the world.
Rohto Pharmaceutical is a manufactures and markets pharmaceuticals and cosmetics products. The Company's products include eyewash, bath soaps, gastrointestinal medicine, and hand cream. Rohto Pharmaceutical also has a license agreement with its subsidiary, Mentholatum (US) to sell their brand products. The Company also manufactures contactlenses and health foods.
Show more...Investment focus
- Industry: Health Care, Manufacturing, Medical
- Stage:Series B, Seed, Series C
- Geography: Japan, Israel, Australia
Investor stats
- Total investments: 11
- Round size: Series B $11M–$103M; Series C $13M–$283M
- Lead/follow: 45% lead, 55% follow
Portfolio highlights
- Fast Beauty — Fast Beauty is a manufacturing company that manufactures beauty products such as hair products, cosmetics, and hair colour.
- Human Life CORD — Human Life Cord specializes in regenerative medicine.
- Australis Scientific — Australis Scientific is a healthcare technology company that develops novel neuromodulation devices to treat lower urinary tract symptoms, including overactive bladder and urinary incontinence. The company designs wearable, non-invasive systems that deliver peripheral nerve stimulation through patch-based devices intended to support bladderfunction management. Its core development work focuses on transcutaneous tibial nerve stimulation technology integrated into compact, user-friendly medical wearables. Australis Scientific also engages in clinical development, device prototyping, and human factors engineering to refine usability and therapeutic performance. The company collaborates with research and healthcare partners to evaluate device effectiveness and support regulatory and clinical validation processes. In addition, Australis Scientific works on product commercialization efforts aimed at bringing neuromodulation-based therapies into broader clinical use for urological care.
We are a community-powered VC fund making pre-seed / seed stage investments in Australian and New Zealand startups. Our community is rallied around a shared goal: to invest in the next generation of Australia and New Zealand startups at the very earliest stage, and then support them on their long a
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Seed, Pre-Seed, Series A
- Geography: Australia, United States, New Zealand
Investor stats
- Total investments: 86
- Round size: Seed $624k–$3.2M; Pre-Seed $410k–$2.2M; Series A $5M–$22M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- OneMRI — A comprehensive whole-body MRI. Radiation-free, clinically reviewed, and explained by doctors.
- Enrola — Looking for online training courses? Discover the perfect course for you with our easy course advisor quiz. Get individual guidance and apply directly.
- BarterAds Pty Ltd — BarterAds is a programmatic advertising exchange that enables businesses to acquire customers without cash spend by converting unused ad inventory into a tradable asset. Instead of paying in fiat, companies earn and spend a proprietary internal currency called Barter Dollars, which are issued when they display ads on their owned media propertiessuch as websites, apps, or platforms.The platform operates as an auction-based exchange, similar to traditional ad networks, where advertisers bid for impressions using Barter Dollars. Inventory is matched contextually and priced dynamically through real-time bidding, ensuring efficient allocation of supply and demand across the network. This allows both advertisers and publishers to maximize the value of otherwise underutilized inventory.BarterAds primarily targets startups, SaaS platforms, marketplaces, gaming companies, and content publishers that have traffic but are constrained by rising customer acquisition costs. By removing the need for upfront cash spend, the platform provides a capital-efficient growth channel, particularly for small and mid-sized businesses.The system includes controls for brand safety, fraud prevention, and inventory quality through business verification, campaign approvals, and continuous monitoring. Barter Dollars are non-transferable and expire periodically, preventing hoarding and ensuring continuous circulation within the ecosystem.BarterAds is designed as a hybrid between barter networks and modern ad exchanges, combining the scalability and automation of programmatic advertising with a closed-loop, cashless economy. The company is headquartered in Australia and is focused on building a global network of advertisers and publishers who both contribute inventory and run campaigns within the platform.
Terra Rossa Capital Pty Ltd operates as a venture capital fund. The Company invests in life science companies. Terra Rossa Capital serves clients in Australia.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Series B
- Geography: Australia
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Signostics — Signostics produces Biotech medical devices. Their flagship product, Signos, allows healthcare professionals to use ultrasound in their clinical practice. It offers ultrasound platform technology that clinicians can place in their pocket or wear around their neck like a stethoscope. Just as handheld devices transformed the business world, it isanticipated the Signos will change the way healthcare professionals practice medicine.Signostics was established in Adelaide, Australia in 2005 and expanded into the U.S. in 2008, dedicated to developing fast and affordable pointâ€ofâ€care medical devices. The company launched its first product into the veterinarian market in January 2009 andgained regulatory approvals to enter the human medical device market for the United States, Europe, and Australia in May 2009. Signostics has offices in Palo Alto, California and Adelaide, South Australia.
Microsoft for Startups is a global program designed to help startups scale with free access to Azure cloud and a streamlined path into selling alongside Microsoft and our vast partner ecosystem.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Seed, Pre-Seed
- Geography: United States, India, Canada
Investor stats
- Total investments: 71
- Lead/follow: no public data
Portfolio highlights
- VitVio — VitVio is a platform built around AI and computer vision with the goal of improving efficiency and quality of care in operating rooms.
- UniPay — UniPay is an eCommerce platform for infrastructure and industry-lacking regions that offers 5 products that enable trust, promote transparency, and enforce accountability.
- Emission Sentri — Drive emission management and reduction with insights
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1482
- Lead/follow: no public data
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Avicella Capital is to identify and finance commercial ventures that ethical and creative entrepreneurs have created to enhance patient outcomes and raise the standard of healthcare.
Show more...Investment focus
- Industry: Therapeutics, Medical, Robotics
- Stage:Series A, Series B
- Geography: Australia
Investor stats
- Total investments: 3
- Round size: Series A $3.1M–$25M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Faeth Therapeutics — Home | Faeth
- Kinoxis Therapeutics — Developing novel therapeutics for social dysfunction and substance use disorders.
- Convergence Medical Robotics — Convergence Medical Robotics is a Brisbane-based pre-clinical medical robotics company making arthroscopy better through the invention of the V01 Robot. It solves the complexity of arthroscopy by creating the world's first arthroscopic robot.
SPRIM Global Investments is a privately held company established in 2008 after SPRIM Consulting & Services expanded globally.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical Device
- Stage:Series A, Debt Financing
- Geography: France, Australia, United States
Investor stats
- Total investments: 13
- Round size: Series A $10M–$22M; Debt Financing $500k–$26M
- Lead/follow: 85% lead, 15% follow
Portfolio highlights
- NinaMED — NinaMED is a healthcare and medical solutions company associated with medical services and technology-enabled healthcare solutions.
- RheumaGen — At RheumaGen, we aim to create a unique and revolutionary therapeutic pathway to cure autoimmune diseases at their source.
- Doron Therapeutics — Doron Therapeutics is a clinical-stage biotechnology company that has developed intra-articular biologic drugs derived from placental tissue and consistently delivers a host of beneficial growth factors with potent anti-inflammatory, tissue-protective, and regenerative capabilities pivotal to the progressive and degenerative disease ofosteoarthritis.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!We are a community focused fund and syndicate investing in frontier mental health: psychedelics, neurotech, precision psychiatry, digital therapeutics, holistic medicine, metabolic psychiatry, digital health, and artificial intelligence.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Canada, Israel
Investor stats
- Total investments: 24
- Round size: Seed $680k–$21M; Pre-Seed $3.5M–$8M; Series A $4.8M–$70M
- Lead/follow: 0% lead, 100% follow
- Last fund: Likely still investing — raised $25M in 2022
Portfolio highlights
- Aerska — Aerska develops targeted RNA medicines to treat brain diseases. By silencing genes that cause harm, we can preserve the minds and memories of those we love.
- Sanmai — Sanmai is a neurotechnology company developing non-invasive ultrasound neurotherapeutics for mental health and neurological disorders
- Jimini Health — Jimini’s mission is to radically improve the efficacy of mental health care across the world. Jimini has developed a novel care model that combines teletherapy sessions with personalized AI support. With Jimini, your therapy care team includes your licensed clinician and Sage, your always-available AI therapy assistant, who work together to helpyou achieve your goals.Founded in 2023 by a team of seasoned AI and biotech entrepreneurs, health tech veterans, and psychology researchers, Jimini puts science and tech first, using safe, purpose-built patient-facing technology that works exclusively under clinical oversight and high safety standards.World leaders in psychology designed Jimini’s care model to ensure that every part of the patient's journey is clinically beneficial. Jimini does not believe that LLMs should replace clinicians; rather, AI will help therapists deliver higher-quality care and focus on the most complex parts of their job. Jimini’s care model is first and foremost led by excellent clinicians.Jimini is committed to improving mental health quality and creating radically better, more modern, and clinically efficacious mental health experiences for patients.
Powerhouse Ventures backs entrepreneurs building the digital infrastructure for rapid decarbonization.
Show more...Investment focus
- Industry: Software, Energy, Solar
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 80
- Round size: Seed $1.1M–$5M; Pre-Seed $1.1M–$1.5M; Series A $3.3M–$30M
- Lead/follow: 14% lead, 86% follow
- Last fund: Likely still investing — raised $70M in 2022
Portfolio highlights
- CVector — Stream, model, and act on your energy and industrial data in real time. CVector unifies asset and market data so you can make faster, smarter project decisions.
- ThinkLabs AI — ThinkLabs AI is a specialist AI development and deployment firm. Its mission is to empower critical industries and infrastructure with trustworthy AI towards global energy sustainability.
- TrustBridge.GG — The premier platform for competitive PlayStation gaming with secure escrow-based competitive gaming. Put your gaming skills to the test and earn real money on the most secure PlayStation competitive gaming platform.
Playford Capital is a venture capital arm of South Australian Government Financing Authority specializing in investments in start-ups, early venture, mid venture, late venture stages, and growth capital.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Series B
- Geography: Australia
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Signostics — Signostics produces Biotech medical devices. Their flagship product, Signos, allows healthcare professionals to use ultrasound in their clinical practice. It offers ultrasound platform technology that clinicians can place in their pocket or wear around their neck like a stethoscope. Just as handheld devices transformed the business world, it isanticipated the Signos will change the way healthcare professionals practice medicine.Signostics was established in Adelaide, Australia in 2005 and expanded into the U.S. in 2008, dedicated to developing fast and affordable pointâ€ofâ€care medical devices. The company launched its first product into the veterinarian market in January 2009 andgained regulatory approvals to enter the human medical device market for the United States, Europe, and Australia in May 2009. Signostics has offices in Palo Alto, California and Adelaide, South Australia.
Skip Capital is a private investment fund investing in technology and infrastructure
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Series A, Series B
- Geography: Australia, United States, Canada
Investor stats
- Total investments: 91
- Round size: Seed $1.4M–$8.5M; Series A $4.4M–$54M; Series B $14M–$94M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- MAKO — Solving human problems with nature’s surfaces.
- Alloy — Alloy enables robotics teams to organise, explore, and evaluate various sorts of multimodal robot data in one platform using natural language, without the need for labels.
- August Robotics — August Robotics creates robots to automate "dirty, dangerous and dull" workflows across the B2B economy. The company's first robot, Lionel, automates the dull and labour intensive task of floor-marking for the global exhibition industry. Lionel has been used as a critical part of the trade show setup process by the world'slargest exhibition companies in Europe and USA. August Robotics' second robot, Diego, automates the dirty and dangerous task of disinfecting high-traffic public areas, such as hotels, offices and aged care centers, optimizing hygiene and reducing the risks of infection. The company is also working on a number of other robots, each leveraging August Robotics' industry leading proprietary mobile robotics platform, which enables August Robotics to generate new robots for new cases far more quickly and cheaply than other robotics companies. The physical world is ripe for disruption by robots, and August Robotics is leading the charge to do this in the B2B segment
Starfish Ventures is an Australian venture capital firm focused on information technology, life sciences, and clean technology companies.
Show more...Investment focus
- Industry: Software, Enterprise Software, Internet
- Stage:Series A, Series B
- Geography: Australia, United States, Philippines
Investor stats
- Total investments: 59
- Round size: Series A $2M–$6.6M; Series B $2.5M–$18M
- Lead/follow: 47% lead, 53% follow
- Last fund: May invest from a new fund soon — raised $162M in 2008
Portfolio highlights
- CAP-XX — CAP-XX makes ultra-thin, high-power supercapacitors for portable and compact devices. Ideal for energy storage. Quotes & samples available.
- Ourcast — Ourcast Inc. has a mobile app that it says can accurately predict precipitation during the next two hours.
- Smart Urban Properties Australia (SUPA) — Smart Urban Properties Australia (SUPA) offers a unique range of property solutions by bringing together renewable energy and mobility, super-speed fiber, and smart prop-tech. It is formed by bringing together Epsilon Security, b.energy, Fibrecorp, Smart Automation Systems, and connecX.
Founded by Steve Baxter, Transition Level Investments provides equity capital and operational expertise across Seed and Series A rounds to Australian companies. Our team focuses on a company-growth approach, adding value by assisting founders to build their expertise, expand their team, build product, scale locally and globally to position for asuccessful exit. We have a track record of identifying investment opportunities in the Australian market and helping enable global growth.
Show more...Investment focus
- Industry: Software, Apps, SaaS
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Australia, United States, Colombia
Investor stats
- Total investments: 27
- Round size: Seed $383k–$2.4M; Series A $14M–$16M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Go1 — Simplify employee training with one subscription that delivers essential learning from 250+ providers, integrated seamlessly into your HR tech stack.
- Picap — Picap is a Colombian ride-hailing service provider that connects people who require a means of transportation and people with motorcycles or cars who want to share their vehicle and earn additional income in the process. Founded in 2016, Picap operates in 13 cities including Bogotá, Medellín, Bucaramanga, Neiva, Villavicencio, Cartagena, Popayán,and Ibagué.
- Cafe X Technologies — Cafe X Technologies is focused on increasing productivity in the service industry through automation. Cafe X Technologies is a privately backed company with funding from Khosla Ventures, Social Capital, Jason Calacanis, Felicis Ventures, Silicon Valley Bank, and The Thiel Foundation.
Yamaha Motor Ventures is investing in early stage startups that are changing the world of Mobility, AgTech, and HealthTech.
Show more...Investment focus
- Industry: Artificial Intelligence, Robotics, Health Care
- Stage:Series A, Seed, Series B
- Geography: United States, Canada, Australia
Investor stats
- Total investments: 52
- Round size: Seed $2M–$13M; Series A $6.5M–$24M; Series B $9.5M–$43M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — raised $100M in 2023
Portfolio highlights
- Ridepanda — Employer sponsored leases on the widest selection of pedal bikes, e-bikes and e-scooters from top brands.
- Sortera Technologies — Sortera Alloys manufactures low-cost, high-quality metal alloys for domestic manufacturing using its artificial intelligence technology. Sortera Alloys is a company based in Fort Wayne, Indiana, and was established in 2020.
- Foundation Alloy — Foundation Alloy makes better parts, faster, for modern engineering.
Giant Leap is Australia's first venture capital fund to be 100% dedicated to investing in exceptional, rapidly scalable impact businesses.
Show more...Investment focus
- Industry: Health Care, Software, Information Technology
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Australia, United States, Philippines
Investor stats
- Total investments: 49
- Round size: Seed $941k–$6.5M; Series A $4.2M–$25M; Venture - Series Unknown $1.3M–$14M
- Lead/follow: 18% lead, 82% follow
- Last fund: May invest from a new fund soon — raised $11M in 2018
Portfolio highlights
- Indi — Connect the village around your child and track what matters. Organise records, therapy goals and your care team in one place.
- Ovum — Meet Ovum, the intelligent health journal mobile app designed for womankind.
- Clean Slate Clinic — We are a for-purpose healthcare company focused on helping Australians keen to detox from alcohol, safely from home.
Ramsay Health Care provides health care services to public and private patients. Its health care services comprise day surgery procedures and complex surgeries, as well as psychiatric care and rehabilitation services. It operates approximately 235 hospitals and day surgery facilities with approximately 25,000 beds in Australia, the United Kingdom,France, Indonesia, Malaysia, Maldives, and Italy. Paul Ramsay founded Ramsay Health Care in 1964. It has its headquarters in Sydney in Australia.
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Series A
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Harrison.ai — Harrison.ai is a clinician-led healthcare AI company using deep learning to improve the odds of IVF success for thousands of patients. The company leverages deep learning to solve the biggest challenges in healthcare and seeks to improve patient outcomes. It empowers physicians and healthcare providers with customized AI-enabled tools thatintegrate into existing clinical workflows which ultimately lead to improved patient outcomes.Harrison.ai uses the deskside DGX Station for experimentation, research, and development. The company uniquely combines exceptional deep learning expertise with clinical experience to develop and deploy healthcare AI solutions. Harrison.ai’s IVY deep learning model analyzes the full five-day video feed from an embryo scope, helping it surpass the performance of AI tools that provide insights based on still images.Harrison.ai's mission is to continuously innovate and commercialize more efficient and more affordable healthcare products and services to healthcare providers and patients.Harrison.ai was founded in 2018 and is headquartered in Barongarook, Victoria, Australia.
Versant partners with exceptional entrepreneurs to build and fund breakthrough biotechnology companies around the globe.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Switzerland, Canada
Investor stats
- Total investments: 317
- Round size: Series A $5M–$78M; Series B $11M–$107M; Series C $12M–$108M
- Lead/follow: 30% lead, 70% follow
- Last fund: Likely still investing — raised $5M in 2024
Portfolio highlights
- Inari Medical — Inari Medical is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. They are focused on treating venous thromboembolism and improving the quality of life of patients suffering from this disease by safely and effectively removing blood clots. It hasdeveloped two minimally-invasive, novel catheter-based mechanical thrombectomy devices that are designed to remove large clots from large vessels and eliminate the need for thrombolytic drugs. The ClotTriever system is 510(k)-cleared by the FDA for thrombectomy in the peripheral vessels and is used to treat patients suffering from deep vein thrombosis. The FlowTriever system is 510(k)-cleared by the FDA for the treatment of pulmonary embolism.The company was founded in 2011 and is headquartered in Irvine, California.
- Gate Bioscience — Gate Bioscience is developing Molecular Gates, a new frontier in protein elimination. Molecular Gates are small molecule drugs that selectively eliminate harmful extracellular proteins at their origin, inside cells, and prevent them from emerging to cause disease.
- Dayra Therapeutics — Dayra Therapeutics manufactures peptide based medicines.
Medical Device VC funding in Australia at a glance
Stats across 237 deals from 191 investors.
Access all 191 VC funds in Australia Medical Device startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Device VC Funds in Australia investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 191 VC funds investing in Australia Medical Device startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!